Evidence map›Paper›PMID 36681733›Full record

ArticleJournal of exposure science & environmental epidemiology2023

An assessment of the ECETOC TRA Consumer tool performance as a screening level tool.

Rosemary T Zaleski, Tatsiana Dudzina, Detlef Keller, Chris Money, Hua Qian, Carlos Rodriguez, Frank Schnöder

Abstract read
In one paragraph

Article in Journal of exposure science & environmental epidemiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosemary T ZaleskiLumina Consulting, L.L.C, Hillsborough, NJ, USA. rzaleski10@gmail.com.ORCID 0000-0002-6379-2645
Tatsiana DudzinaExxonMobil Biomedical Sciences, Inc., Machelen, Belgium.
Detlef KellerHenkel AG & Co KGaA, Düsseldorf, Germany.
Chris MoneyCynara Consulting, Brockenhurst, UK.
Hua QianExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA.
Carlos RodriguezProcter and Gamble, Strombeek-Bever, Belgium.
Frank SchnöderDuPont de Nemours Deutschland GmbH, Neu-Isenburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Targeted Risk Assessment (TRA) Consumer tool was developed to fill in a methodology gap for a high throughput, screening level tool to support industry compliance with the European Union's Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation.

objectiveTo evaluate if the TRA Consumer tool has met its design of being a screening level tool (i.e., one which does not under-predict potential exposures).

methodsThe TRA Consumer tool algorithms and defaults were reviewed and performance benchmarked vs. other consumer models and/or empirical data. Findings from existing reviews of the TRA consumer tool were also considered and addressed.

resultsTRA predictions based on its default inputs exceeded measured exposures when available, typically by orders of magnitude, and were generally greater than or similar to those of other consumer exposure tools. For dermal exposure from articles, there was no evidence that a diffusivity approach would provide more appropriate exposure estimates than those of the TRA. When default values are refined using more specific data, the refined values must be considered holistically to reflect the situation being modeled as some parameters may be correlated. SIGNIFICANCE: This is the first evaluation of the ECETOC TRA consumer tool in its entirety, considering algorithms, input defaults, and associated predictions for consumer products and articles. The evaluation confirmed its design as a screening level tool. IMPACT STATEMENT: The ECETOC TRA Consumer tool has been widely applied to generate exposure estimates to support chemical registrations under the EU REACH regulation. This evaluation supports the appropriateness of the TRA as a screening level exposure assessment tool. It also warrants additional measurements of consumer exposure, especially for article use scenarios, to aid the development of consumer exposure tools and chemical risk assessment.

Indexed as

EcotoxicologyOccupational ExposureAlgorithmsHumansIndustryRisk AssessmentConsumer exposureDermal exposureECETOC Targeted Risk Assessment tool (ECETOC TRA)Inhalation exposureOral exposureRegistration, Evaluation, Authorization, and Restriction of Chemicals (REACH)

Identifiers

PMID36681733
PMCPMC10733139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.